Abacus Planning Group, Inc. Cerus Corp Transaction History

Abacus Planning Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 15, 2019	BUY	$4.89 - $7.16 $50,474 - $73,905	10,322 Added 749.06%	11,700 $59,000
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $50,474 - $73,905	-10,322 Reduced 88.22%	1,378 $262,000
Q4 2017 Mar 06, 2018	BUY	$2.76 - $3.95 $32,291 - $46,215	11,700	11,700 $40,000

159

146M

48.6K

8.7K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $271M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Abacus Planning Group, Inc. with notifications on news.